Literature DB >> 21692658

Transcriptional control of the terminal fate of monoaminergic neurons.

Nuria Flames1, Oliver Hobert.   

Abstract

Monoaminergic neurons are critical functional components of all nervous systems across phylogeny. The terminally differentiated state of individual types of monoaminergic neurons is defined by the coordinated expression of a battery of genes that instructs the synthesis and transport of specific monoamines, such as serotonin or dopamine. Dysfunction or deregulation of several of these enzymes and transporter system has been proposed to be the underlying basis of several pathological conditions. We review here the state of knowledge of the nature of the transcriptional regulatory programs that control the expression of what we term monoaminergic gene batteries (enzymes and transporters for specific monoamines) and thereby define the terminally differentiated state of monoaminergic neurons. We review several case studies in vertebrate and invertebrate model systems and propose that the coordinated expression of the genes that define individual monoaminergic cell types may be brought about by transcriptional coregulatory strategies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21692658     DOI: 10.1146/annurev-neuro-061010-113824

Source DB:  PubMed          Journal:  Annu Rev Neurosci        ISSN: 0147-006X            Impact factor:   12.449


  29 in total

1.  Egr-1 induces DARPP-32 expression in striatal medium spiny neurons via a conserved intragenic element.

Authors:  Serene Keilani; Samira Chandwani; Georgia Dolios; Alexey Bogush; Heike Beck; Antonis K Hatzopoulos; Gadiparthi N Rao; Elizabeth A Thomas; Rong Wang; Michelle E Ehrlich
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

Review 2.  Effects of prenatal methamphetamine exposure: a review of cognitive and neuroimaging studies.

Authors:  Maja A Kwiatkowski; Annerine Roos; Dan J Stein; Kevin G F Thomas; Kirsty Donald
Journal:  Metab Brain Dis       Date:  2013-12-28       Impact factor: 3.584

3.  Neuronal development genes are key elements mediating the reinforcing effects of methamphetamine, amphetamine, and methylphenidate.

Authors:  Ike Dela Peña; Se Jin Jeon; Eunyoung Lee; Jong Hoon Ryu; Chan Young Shin; Minsoo Noh; Jae Hoon Cheong
Journal:  Psychopharmacology (Berl)       Date:  2013-06-20       Impact factor: 4.530

4.  A combinatorial regulatory signature controls terminal differentiation of the dopaminergic nervous system in C. elegans.

Authors:  Maria Doitsidou; Nuria Flames; Irini Topalidou; Namiko Abe; Terry Felton; Laura Remesal; Tatiana Popovitchenko; Richard Mann; Martin Chalfie; Oliver Hobert
Journal:  Genes Dev       Date:  2013-06-15       Impact factor: 11.361

Review 5.  Nuclear receptors in neural stem/progenitor cell homeostasis.

Authors:  Dimitrios Gkikas; Matina Tsampoula; Panagiotis K Politis
Journal:  Cell Mol Life Sci       Date:  2017-06-21       Impact factor: 9.261

Review 6.  Neural Subtype Specification from Human Pluripotent Stem Cells.

Authors:  Yunlong Tao; Su-Chun Zhang
Journal:  Cell Stem Cell       Date:  2016-11-03       Impact factor: 24.633

Review 7.  Serotonin neuron diversity in the dorsal raphe.

Authors:  Rodrigo Andrade; Samir Haj-Dahmane
Journal:  ACS Chem Neurosci       Date:  2013-01-16       Impact factor: 4.418

Review 8.  Gene regulatory networks in cardiac conduction system development.

Authors:  Nikhil V Munshi
Journal:  Circ Res       Date:  2012-05-25       Impact factor: 17.367

9.  A transcription factor collective defines the HSN serotonergic neuron regulatory landscape.

Authors:  Carla Lloret-Fernández; Miren Maicas; Carlos Mora-Martínez; Alejandro Artacho; Ángela Jimeno-Martín; Laura Chirivella; Peter Weinberg; Nuria Flames
Journal:  Elife       Date:  2018-03-22       Impact factor: 8.140

10.  The SWI/SNF chromatin remodeling complex selectively affects multiple aspects of serotonergic neuron differentiation.

Authors:  Peter Weinberg; Nuria Flames; Hitoshi Sawa; Gian Garriga; Oliver Hobert
Journal:  Genetics       Date:  2013-03-02       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.